Unity Biotechnology, Inc. Net Change in Cash
Unity Biotechnology, Inc. reported Net Change in Cash of $419.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-04-22
- Unity Biotechnology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $419.00K.
- Unity Biotechnology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$12.37M, a 220.88% decline year-over-year.
- Unity Biotechnology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $10.24M.
- Unity Biotechnology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$16.46M, a 282.17% decline year-over-year.
- Unity Biotechnology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$12.22M, a 272.96% decline from fiscal 2023.
- Unity Biotechnology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $7.07M.
- Unity Biotechnology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$20.72M, a 237.23% decline from fiscal 2021.
- Unity Biotechnology, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $15.10M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2025-03-31 | $419.00K 10-Q · filed 2025-04-22 | |||
| 2024-12-31 | -$12.22M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | -$10.90M 10-Q · filed 2024-11-04 | |||
| 2024-06-30 | -$12.22M 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | -$12.37M 10-Q · filed 2025-04-22 | |||
| 2023-12-31 | $7.07M 10-K · filed 2025-03-07 | |||
| 2023-09-30 | -$4.86M 10-Q · filed 2024-11-04 | |||
| 2023-06-30 | $6.38M 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | $10.24M 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | -$20.72M 10-K · filed 2025-03-07 | |||
| 2022-09-30 | -$10.33M 10-K · filed 2024-04-15 | |||
| 2022-06-30 | -$13.46M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | -$16.46M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $15.10M 10-K · filed 2024-04-15 | |||
| 2021-09-30 | $4.19M 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | -$4.31M 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | $9.04M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$19.67M 10-K · filed 2023-03-15 | |||
| 2020-09-30 | $11.11M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $2.12M 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | -$12.41M 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | $22.97M 10-K · filed 2022-03-15 | |||
| 2019-09-30 | $22.27M 10-Q · filed 2020-11-04 | |||
| 2019-06-30 | $8.61M 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $19.75M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $8.10M 10-K · filed 2021-03-23 | |||
| 2018-09-30 | $21.60M 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $26.87M 10-Q · filed 2019-08-07 | |||
| 2017-12-31 | -$81.89M 10-K · filed 2020-03-11 |